Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial-Reference-Cited by-同舟云学术

Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial

Published:2021-08 Issue:2 Volume:162 Page:382-388
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Sharma Aparna,Singh Mayank,Chauhan Ravi,Malik Prabhat Singh,Khurana Sachin,Mathur Sandeep,Kumar Sunesh,Sreenivas Vishnubhatla,Kumar Lalit

Funder

Department of Health Research, India

Indian Council of Medical Research

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference30 articles.

1. Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials;Markman;Gynecol. Oncol.,2004

2. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy;Hanker;Ann. Oncol.,2012

3. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial;Pujade-Lauraine;J. Clin. Oncol.,2014

4. Metronomics: towards personalized chemotherapy?;André;Nat. Rev. Clin. Oncol.,2014

5. Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: a retrospective analysis;Sharma;Indian J. Med. Res.,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of VEGFR inhibitors for recurrent ovarian cancer: a systematic review;Future Oncology;2024-08-12

2. Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression;Scientific Reports;2024-07-03

3. New hopes and promises in the treatment of ovarian cancer focusing on targeted treatment—a narrative review;Frontiers in Pharmacology;2024-06-14

4. Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy;Frontiers in Cell and Developmental Biology;2024-05-15

5. Systematic Review of the Literature on Multiple Co-occurring Symptoms in Patients Receiving Treatment for Gynecologic Cancers;Seminars in Oncology Nursing;2024-02